Precision BioSciences, Inc.
Entity

  • Precision BioSciences, Inc.

    Created in 2006


  • Up & running (A)
    Existing signals show a regular activity

  • Social networks

    1,365 21,279

  • Activities

    biotech deeptech

  • Technologies

    Synthetic Biology

  • Entity types

    SMB

  • Location

    302 E Pettigrew St, Durham, NC 27701, USA

    Durham

    United States of America

  • Employees

    Scale: 51-200

    Estimated: 123

  • Engaged catalyst

    3
    0 0

  • Added in Motherbase

    3 years ago
Description
  • Value proposition

    Dedicated to Improving Life.

    Precision BioSciences, Inc. (Nasdaq: DTIL) is a clinical stage gene editing company developing in vivo gene editing with its highly precise and versatile ARCUS genome editing platform. ARCUS uses sequence-specific DNA-cutting enzymes, or nucleases designed for gene knock out, as well as highly complex edits for gene insertion and/or gene repair. Precision BioSciences is based in Durham, North Carolina. For more information about Precision BioSciences please visit www.precisionbiosciences.com.

    Gene Editing and Gene Therapy

Catalyst interactions
Catalyst TypeTweets Articles
Biogen
Biogen
Biotechnology, Biotechnology Research
Biogen
Biotechnology, Biotechnology Research 		Other

13 Apr 2021


Bristol Myers Squibb
Bristol Myers Squibb
Pharmaceutical, Pharmaceutical Manufacturing
Bristol Myers Squibb
Pharmaceutical, Pharmaceutical Manufacturing 		Other

8 Mar 2019


Novartis
Novartis
Pharmaceutical, Pharmaceutical Manufacturing
Novartis
Pharmaceutical, Pharmaceutical Manufacturing 		Other

24 Jul 2022


Social network dynamics
Similar entities
BETA
Last news
Show all articles